IFNB1 and neoplasm: The results showed that compared to cGAMP, XA5508 could significantly increase the expression levels of immune factors IFN-β, IFN-γ, IL-2, IL-6, and TNFα in the mice (Figure 5F–H,J,K), and significantly reduce the expression of the immunosuppressive tumor-promoting factor IL-10 (Figure 5I).